# FDA Inspection 1220016 - Karen L. Kotloff, MD - September 15, 2023

Source: https://www.keypedia.com/records/fda_inspections/karen-l-kotloff-md/b80d40e6-c320-4bf7-a93b-40fcf8af9b66
Source feed: FDA_Inspections

> FDA Inspection 1220016 for Karen L. Kotloff, MD on September 15, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1220016
- Company Name: Karen L. Kotloff, MD
- Inspection Date: 2023-09-15
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 870732 - 2014-03-20](https://www.keypedia.com/records/fda_inspections/karen-l-kotloff-md/c8529e6d-dbcf-4c29-a671-8e757904ccef)

Company: https://www.keypedia.com/companies/karen-l-kotloff-md/626eac87-a09f-4709-8a88-95bb5db97404

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d